Pharma Journalist

Developments in Protein Engineering An interview with panelist: Maria Lucas, CEO, Zymvol

By Pharma Journalist on September 14, 2021

Related Posts

Direct RNA Binding Emerges as a Powerful Approach for Functional Disease Modulation

AI, Structure Prediction and Advanced Computational Tools Transform RNA Target Discovery

New Preclinical Data and Translational Advances Set to Take Center Stage at RNA-Targeted Drug Discovery Summit

FDA, Health Canada & Leading Biopharma Organizations Unite at the 2nd Model-Informed Drug Development Summit

Industry Leaders Convene in Boston as Registration Remains Open for the 4th TRP Supply Chain & Manufacturing Summit

Who Is Shaping the Future of RNA-Targeted Drug Discovery? Industry Leaders to Gather in Boston This November

World ADC Awards 2026 Shortlist Announced, Recognizing Excellence Across the ADC Industry
Comments (0)
Add Comment